Loading data
CRSPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.51 m USD | 37.31 m USD | 371.21 m USD | 1.2 m USD | 914.96 m USD |
| Research and development expense | 284.81 m USD | 310.24 m USD | 387.33 m USD | 461.65 m USD | 340.57 m USD |
| Operating profit | -664.57 m USD | -466.57 m USD | -222.54 m USD | -673.16 m USD | 373.53 m USD |
| Profit before tax | -577.97 m USD | -362.67 m USD | -150.72 m USD | -650.5 m USD | 379.53 m USD |
| Income tax expense | 3.63 m USD | 3.59 m USD | 2.89 m USD | -325 k USD | 1.87 m USD |
| Net income (reported basis) | -581.6 m USD | -366.25 m USD | -153.61 m USD | -650.18 m USD | 377.66 m USD |
| Basic earnings per share | -6.47 USD/share | -4.34 USD/share | -1.94 USD/share | -8.36 USD/share | 4.97 USD/share |
| Diluted earnings per share | -6.47 USD/share | -4.34 USD/share | -1.94 USD/share | -8.36 USD/share | 4.7 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.